A Novel Curcumin-Galactomannoside Complex Delivery System Improves Hepatic Function Markers in Chronic Alcoholics: A Double-Blinded, randomized, Placebo-Controlled Study

Table 1

Comparison of baseline and anthropometric characteristics between CGM and placebo groups.

	Initial		Final
	CGM	Placebo	CGM	Placebo
Age	45± 9.1
Gender	Male
Height (in cm)	165.7± 6.2
Body weight (kg)	73.45±6.1	73.2±8.9	72.2±7.1	70.12±5.2
BMI (kg/m^2)	31.2±3.6	30.10±5.0	30.8±3.5	29.88±4.5
SBP (mmHg)	124.41±3.2	126±3.4	121.3±3.4	124.7±3.3
DBP (mmHg)	83.3±6.4	86.23±5.1	82.52±4.8	84.54±2.7
Hb (g/dL)	13.2±1.16	13.4±0.88	13.5±1.19	13.0±0.70
Creatinine (g/dL)	1.18±0.2	1.1±0.2	1.1±0.2	1.09±1.8
Cholesterol (mg/dL)	245.2±30.2	243.8±30.3	234.3±20.1	258.2±32.7
HDL (mg/dL)	45.21±4.2	42.55±5.5	53.21±4.3	40.21±4.1
LDL (mg/dL)	109.2±21.5	112.7±17.5	100.4±15.1	120.7±18.1
Triglyceride (mg/dL)	199.5±49.5	189±28.6	176.2±42.7	191.3±34.2

SBP: systolic blood pressure.
DBP: diastolic blood pressure.
BMI: body mass index.
Hb: haemoglobin.
HDL: high density lipoprotein.
LDL: low density lipoprotein.